ConductScience.org, home

Paper7238564

Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.

Pentikäinen PJ and 2 others. Eur J Clin Pharmacol, 1981. Cited by 60 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. Papers, record 7238564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7238564

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1981
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.59
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pentikäinen PJP J
2Neuvonen PJP J
3Backman CC

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory AgentsMajor topic
ortho-AminobenzoatesMajor topic
Administration, Oral
Adult
Biological Availability
Female
Glucuronates
Humans
Infusions, Parenteral
Intestinal Absorption
Kinetics
Models, Biological
Protein Binding

Source PubMed

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1579,121[On biochemistry and pharmacokinetics of etofenamate/studies in man (author's transl)].Arzneimittelforschung1977https://conductscience.org/library/papers/579121PubMed
21,086,507Prolonged treatment with tolfenamic acid in inflammatory rheumatic diseases.Scand J Rheumatol1976https://conductscience.org/library/papers/1086507PubMed
35,652,110Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.J Pharm Sci1968https://conductscience.org/library/papers/5652110PubMed
4432,132[Mefenamic acid pharmacokinetics in patients with congestive heart failure].Pol Tyg Lek1979https://conductscience.org/library/papers/432132PubMed
5373,084A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis.Scand J Rheumatol Suppl1979https://conductscience.org/library/papers/373084PubMed
6527,637The pharmacokinetics of diclofenac sodium following intravenous and oral administration.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/527637PubMed
7387,372Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.Drugs1979https://conductscience.org/library/papers/387372PubMed
8824,724Inhibition of prostaglandin biosynthesis by tolfenamic acid in vitro.Scand J Rheumatol1976https://conductscience.org/library/papers/824724PubMed
95,671,338New method for calculating the intrinsic absorption rate of drugs.J Pharm Sci1968https://conductscience.org/library/papers/5671338PubMed
105,151,301Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.Eur J Clin Pharmacol1971https://conductscience.org/library/papers/5151301PubMed
1189,390Tolfenamic acid is as effective as ergotamine during migraine attacks.Lancet1979https://conductscience.org/library/papers/89390PubMed
12707,953[Pharmacokinetic profil of ketoprofen (author's transl)].Ann Pharm Fr1978https://conductscience.org/library/papers/707953PubMed
134,979,052Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.Ann Phys Med1966https://conductscience.org/library/papers/4979052PubMed
14324,748Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.Drugs1977https://conductscience.org/library/papers/324748PubMed
155,411,325Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.J Pharm Sci1970https://conductscience.org/library/papers/5411325PubMed

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
41,362,921Antagonistic drug interactions protect commensal Bacteroidaceae from macrolides via an RND-type efflux pump.Gut Microbes2025https://conductscience.org/library/papers/41362921PubMed
38,952,278Pharmacokinetics, bioavailability and plasma protein binding of tolfenamic acid in rainbow trout (Oncorhynchus mykiss).Vet Med Sci2024https://conductscience.org/library/papers/38952278PubMed
37,440,786Copper-catalyzed N-arylation of amines with aryliodonium ylides in water.Beilstein J Org Chem2023https://conductscience.org/library/papers/37440786PubMed
37,291,774Analysis of Tolfenamic Acid using a Simple, Rapid, and Stability-indicating Validated HPLC Method.Antiinflamm Antiallergy Agents Med Chem2024https://conductscience.org/library/papers/37291774PubMed
36,834,716Enhanced NSAIDs Solubility in Drug-Drug Formulations with Ciprofloxacin.Int J Mol Sci2023https://conductscience.org/library/papers/36834716PubMed
36,350,125Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae.Microbiol Spectr2022https://conductscience.org/library/papers/36350125PubMed
35,215,645Polyelectrolyte Multilayer Films as a Potential Buccal Platform for Drug Delivery.Polymers (Basel)2022https://conductscience.org/library/papers/35215645PubMed
32,393,483Repurposing Fenamic Acid Drugs To Combat Multidrug-Resistant Neisseria gonorrhoeae.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32393483PubMed
30,737,267Identification of Novel Inhibitors of Auxin-Induced Ca2+ Signaling via a Plant-Based Chemical Screen.Plant Physiol2019https://conductscience.org/library/papers/30737267PubMed
24,073,394Development and characterization of novel polyurethane films impregnated with tolfenamic acid for therapeutic applications.Biomed Res Int2013https://conductscience.org/library/papers/24073394PubMed
17,618,427Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation.Eur J Clin Pharmacol2007https://conductscience.org/library/papers/17618427PubMed
8,983,935Pharmacokinetics of tolfenamic acid in pediatric patients after single oral dose.Eur J Drug Metab Pharmacokinet1995https://conductscience.org/library/papers/8983935PubMed
7,708,126Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.Naunyn Schmiedebergs Arch Pharmacol1994https://conductscience.org/library/papers/7708126PubMed
7,166,179Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.Eur J Drug Metab Pharmacokinet1982https://conductscience.org/library/papers/7166179PubMed
7,166,178Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites.Eur J Drug Metab Pharmacokinet1982https://conductscience.org/library/papers/7166178PubMed
6,691,890Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6691890PubMed
6,508,975Do gastric contents modify antidotal efficacy of oral activated charcoal?Br J Clin Pharmacol1984https://conductscience.org/library/papers/6508975PubMed
6,352,138Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6352138PubMed
6,334,608Pharmacokinetics of tolfenamic acid: disposition in bile, blood and urine after intravenous administration to man.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6334608PubMed
3,876,221Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3876221PubMed

See all 26 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7238564

GET https://conductscience.org/api/papers/v1/7238564/cited_by?page=2